Peter Tcherveniakov
St James's University Hospital, Beckett Street
Leeds, ENG LS97TF, United Kingdom
Leeds, ENG LS97TF, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Is Neoadjuvant Chemoimmunotherapy Safe in Surgically High-Risk Lung Cancer Patients? A Single-Centre IPTW Analysis.
Journal: Journal of clinical medicine
Published: June 14, 2026
Benchmarking Large Language Models Using a Best Evidence Topic Report in a Patient With Early Non-Small Cell Lung Cancer.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 14, 2025
Outcome of stage-eligible patients not receiving neoadjuvant chemo-immunotherapy for clinical or procedural reasons: a real practice analysis.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 30, 2025
Risk Factors Associated With Locoregional Recurrence Following Pulmonary Segmentectomy for Clinical Stage IA1-2 NSCLC: A Real Clinical Practice Analysis.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: September 29, 2025
Assessment of patient-reported symptom and psychological distress after neoadjuvant chemo-immunotherapy and lung resection for non-small cell lung cancer.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: September 24, 2025
A Multifactorial Model to Predict the Surgical Complexity of Lung Resection After Neoadjuvant Chemoimmunotherapy.
Journal: Annals of thoracic surgery short reports
Published: September 15, 2025
Last-minute cancellation of elective lung cancer surgery is associated with poorer survival.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: September 10, 2024
Self-reported dyspnoea and shortness of breathing deterioration in long-term survivors after segmentectomy or lobectomy for early-stage lung cancer.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: March 26, 2024
Oncologic outcomes after minimally invasive segmentectomy or lobectomy in patients with hypermetabolic clinical stage IA1-2 non-small cell lung cancer.
Journal: JTCVS open
Published: March 03, 2024
Impact of lung cancer screening on surgical stage distribution and surgical practice: a regional analysis of patients operated in and out of a screening program.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 16, 2023
Minimally invasive segmentectomy and lobectomy for peripheral stage IA1-2 non-small-cell lung cancer: a case-matched cohort study from a UK Centre.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 14, 2023
Last Updated: 09/26/2026